Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule
暂无分享,去创建一个
A. Schuchat | J. Swanson | R. Baltimore | R. Frenck | B. Schwartz | L. Rubin | M. Fischer | M. Brady | H. Bernstein | R. Clover | J. Bradley | J. Bocchini | C. Baker | L. Pickering | D. Kimberlin | M. Fisher | P. Dennehy | R. Gorman | J. Starke | S. Long | E. O. Ledbetter | D. Pratt | J. Mcmillan | Alison Siwek
[1] A. Fiks,et al. Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post–Vaccine Licensure Era , 2009, Pediatrics.
[2] J. Seward,et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[3] D. Kimberlin,et al. Varicella-zoster vaccine for the prevention of herpes zoster. , 2007, The New England journal of medicine.
[4] J. Stockman. Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children , 2007 .
[5] D. Karras,et al. Update on emerging infections: news from the Centers for Disease Control and Prevention. Varicella outbreak among vaccinated children--Nebraska, 2004. , 2007, Annals of emergency medicine.
[6] D. Michalik. Primary Immune Failure After One Dose of Varicella Vaccine Are Likely a Cause of Breakthrough Infections in Healthy Vaccinated Children. , 2006 .
[7] R. Harpaz,et al. Secondary transmission of varicella vaccine virus in a chronic care facility for children. , 2006, The Journal of pediatrics.
[8] Laura Zimmerman,et al. One Dose of Varicella Vaccine Does Not Prevent School Outbreaks: Is it Time for a Second Dose? , 2006, Pediatrics.
[9] E. Rothstein,et al. Safety and Immunogenicity of a Measles, Mumps, Rubella and Varicella Vaccine Given With Combined Haemophilus influenzae Type b Conjugate/Hepatitis B Vaccines and Combined Diphtheria-Tetanus-Acellular Pertussis Vaccines , 2006, The Pediatric infectious disease journal.
[10] Varicella outbreak among vaccinated children--Nebraska, 2004. , 2006, MMWR. Morbidity and mortality weekly report.
[11] A. Shefer,et al. Impact of varicella vaccination on health care utilization. , 2005, JAMA.
[12] K. Reisinger,et al. Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children , 2005, The Pediatric infectious disease journal.
[13] P. Peduzzi,et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.
[14] E. Hayes,et al. Importance of Catch-up Vaccination: Experience From a Varicella Outbreak, Maine, 2002–2003 , 2005, Pediatrics.
[15] J. Seward,et al. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. , 2005, The New England journal of medicine.
[16] A. Gershon. Contagiousness of varicella in vaccinated cases: a household contact study. , 2005, The Journal of pediatrics.
[17] R. Harpaz,et al. Chickenpox Outbreak in a Highly Vaccinated School Population , 2004, Pediatrics.
[18] D. Krysan. Effectiveness over time of varicella vaccine. , 2004, The Journal of pediatrics.
[19] Mitesh S. Patel,et al. Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United States , 2004, Pediatrics.
[20] K. Ehresmann,et al. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. , 2004, The Journal of infectious diseases.
[21] K. Reisinger,et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine , 2004, The Pediatric infectious disease journal.
[22] J. Blostein,et al. Outbreak of varicella among vaccinated children--Michigan, 2003. , 2004, MMWR. Morbidity and mortality weekly report.
[23] M. Levin,et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. , 2003, The Journal of infectious diseases.
[24] D. Schmid,et al. A Cluster of Primary Varicella Cases Among Healthcare Workers With False-Positive Varicella Zoster Virus Titers , 2003, Infection Control & Hospital Epidemiology.
[25] P. Kilgore,et al. Varicella in Americans from NHANES III: Implications for control through routine immunization , 2003, Journal of medical virology.
[26] J. Heyse,et al. Use of statistical models for evaluating antibody response as a correlate of protection against varicella , 2002, Statistics in medicine.
[27] J. Seward,et al. Hospitalizations for varicella in the United States, 1988 to 1999 , 2002, The Pediatric infectious disease journal.
[28] A. Ratner. Varicella-related hospitalizations in the vaccine era , 2002, The Pediatric infectious disease journal.
[29] J. Lumpkin,et al. An Outbreak of Varicella among children attending preschool and elementary school in Illinois. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] J. Seward,et al. Younger age at vaccination may increase risk of varicella vaccine failure. , 2002, The Journal of infectious diseases.
[31] J. Heyse,et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection , 2002, The Pediatric infectious disease journal.
[32] L. Saiman,et al. Persistence of immunity to live attenuated varicella vaccine in healthy adults. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] L. Mascola,et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. , 2002, JAMA.
[34] W. Edmunds,et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom , 2001, Epidemiology and Infection.
[35] L. Barker,et al. National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999. , 2001, American journal of preventive medicine.
[36] L. Saiman,et al. Persistence of Immunity to Varicella-Zoster Virus After Vaccination of Healthcare Workers , 2001, Infection Control & Hospital Epidemiology.
[37] E. Shapiro,et al. The effectiveness of the varicella vaccine in clinical practice. , 2001, The New England journal of medicine.
[38] W. P. Stephenson,et al. The postmarketing safety profile of varicella vaccine. , 2000, Vaccine.
[39] M. Wharton,et al. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. , 2000, The Journal of infectious diseases.
[40] U. Buchholz,et al. Varicella Outbreaks After Vaccine Licensure: Should They Make You Chicken? , 1999, Pediatrics.
[41] Bruce G. Weniger,et al. Combination Vaccines for Childhood Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) * , 1999, Pediatrics.
[42] S. M. Hewitt. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1999, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[43] P. Strebel,et al. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. , 1997, JAMA.
[44] P. LaRussa,et al. Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. , 1997, The Journal of pediatrics.
[45] B. Yawn,et al. Community impact of childhood varicella infections. , 1997, The Journal of pediatrics.
[46] M. Wharton,et al. The epidemiology of varicella-zoster virus infections. , 1996, Infectious disease clinics of North America.
[47] D. Klinman,et al. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. , 1995, The Journal of pediatrics.
[48] E. Rothstein,et al. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. , 1995, The Journal of infectious diseases.
[49] B. Watson. HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES IN HEALTHY CHILDREN AFTER ONE OR TWO DOSES OF VARICELLA VACCINE , 1995 .
[50] R. Jacobs,et al. Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases. , 1995, Pediatrics.
[51] H. Matthews,et al. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adults , 1995 .
[52] Larry K. Pickering,et al. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[53] B. J. Meade,et al. Age-specific incidence of chickenpox. , 1994, Public health reports.
[54] T. Randall,et al. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. , 1994, The Journal of infectious diseases.
[55] J. Struewing,et al. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. , 1993, American journal of public health.
[56] I. Hardy,et al. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. , 1991, The New England journal of medicine.
[57] D. Morton,et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. , 1991, Vaccine.
[58] A. Gershon,et al. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test , 1991, Journal of clinical microbiology.
[59] G. Calandra,et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. , 1991, Pediatrics.
[60] D. Morton,et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. , 1991, Vaccine.
[61] H. Kjersem,et al. Varicella Among Immigrants from the Tropics, a Health Problem , 1990, Scandinavian journal of social medicine.
[62] P. Robertson,et al. Determination and importance of varicella immune status of nursing staff in a children's hospital. , 1990, The Journal of hospital infection.
[63] Henry Nider,et al. Report of the Committee on Infectious Diseases , 1989 .
[64] L. Leibovici. Daily change of an antiseptic dressing does not prevent infusion phlebitis: a controlled trial. , 1989, American journal of infection control.
[65] M. Horowitz,et al. Susceptibility of hospital-based health care personnel to varicella-zoster virus infections. , 1989, American journal of infection control.
[66] P. LaRussa,et al. Immunization of healthy adults with live attenuated varicella vaccine. , 1988, The Journal of infectious diseases.
[67] S. Plotkin,et al. Varicella vaccine studies in healthy children and adults. , 1986, Pediatrics.
[68] S. Alter,et al. Susceptibility to Varicella-Zoster Virus Among Adults at High Risk for Exposure , 1986, Infection Control.
[69] R. Locksley,et al. Infection with varicella-zoster virus after marrow transplantation. , 1985, The Journal of infectious diseases.
[70] L. Melton,et al. Epidemiology of herpes zoster in children and adolescents: a population-based study. , 1985, Pediatrics.
[71] E. Scolnick,et al. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. , 1984, The New England journal of medicine.
[72] A. Gershon,et al. Clinical reinfection with varicella-zoster virus. , 1984, The Journal of infectious diseases.
[73] R. Tedder,et al. Antibody assays for varicella‐zoster virus: Comparison of competitive enzyme‐linked immunosorbent assay (ELISA), Competitive radioimmunoassay (RIA), Complement fixation, and indirect immunofluorescence assays , 1984, Journal of medical virology.
[74] T. D. Cain,et al. Immune responses to varicella-zoster in the aged. , 1982, Archives of Internal Medicine.
[75] M. Just,et al. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged , 1981, Infection and immunity.
[76] J. Dudgeon,et al. Varicella-zoster infections. , 2012, Major problems in clinical pediatrics.
[77] Y. Okuno,et al. Live vaccine used to prevent the spread of varicella in children in hospital. , 1974, Lancet.
[78] J. Meyers. Congenital varicella in term infants: risk reconsidered. , 1974, The Journal of infectious diseases.
[79] D. L. Crombie,et al. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis , 1965, Proceedings of the Royal Society of Medicine.
[80] Hope-Simpson Re. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. , 1965 .
[81] A H ROSS,et al. Modification of chicken pox in family contacts by administration of gamma globulin. , 1963, The New England journal of medicine.
[82] Ross Ah,et al. Modification of Chicken Pox in Family Contacts by Administration of Gamma Globulin , 1962 .
[83] D. Tayloe,et al. Pediatrics , 1927, The Indian Medical Gazette.